Sep 26,2018

2/3s of commercially available blood glucometers don't meet FDA accuracy standards, study finds

In a triple-blinded, multisite, independent study, researchers have found that only one third of commercially available FDA-cleared blood glucose meters in the United States could consistently perform to an accuracy standard close to, but actually more lenient than, the FDA’s. Of the 18 BCGs tested, only six were consistently accurate in each of three test sites. Five were compliant in two out of three sites, three in just one, and four failed in all three sites.

CLINICAL STUDY

#bgm

View Analyst & Ambassador Comments
Go to original news
Feb 19,2021

MyWay Digital Health is now ISO 27001 certified

MyWay Digital Health are pleased to announce that MyWay Digital Health has joined the same league of companies such as Google, Apple and Intel, by becoming ISO 27001 certified.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Feb 19,2021

My Diabetes My Way app now available for patients in Scotland and Somerset

MyWay Digital Health's new My Diabetes My Way app has now been launched for patients both in Scotland and Somerset. The app offers users the opportunity to access their own personal records and advice on the go and makes it much easier for patients to submit their home readings when they’re not able to access their computer. It is available to download on iOS and android through the app store or Google play.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Feb 19,2021

Startup Summit Competition Finalist!

MyWay Digital Health were delighted to find out this week that Debbie Wake and MyWay Digital Health have been selected as finalists in the Startup Summit competition! The winner is awarded a fully funded place on the Silicon Valley Accelerate programme where entrepreneurs are given an insight into the culture and strategy of some of the world’s most innovative organisations operating out of San Francisco and Silicon Valley.

View Analyst & Ambassador Comments
Go to original news
Sep 01,2018

Self-monitoring of blood glucose in insulin-treated diabetes: a multicase study

Researchers conducted a multicase study among ten people with type 1 and insulin-treated type 2 diabetes mellitus in Scotland, alongside seven nominated support people and four healthcare professionals. All participants were interviewed in depth and six participants provided SMBG ( self-monitoring of blood glucose) diaries. Stones’ version of structuration theory informed the analysis.

CLINICAL STUDY

#bgm

View Analyst & Ambassador Comments
Go to original news
Sep 04,2018

DIAMONTECH COLLECTS 5 MILLION EUROS

DiaMonTech GmbH, a technology company specializing in methods for non-invasive blood glucose measurement, has successfully completed its second round of financing. The company received a total of around 5 million euros from old and new investors. The IBB Beteiligungsgesellschaft from Berlin, the Japanese electronics group Macnica and the Chinese venture capitalist Jindong Capital are the largest investors. DiaMonTech intends to use the money to advance the development of non-invasive blood sugar measurement with its patented, optical process.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 05,2018

DarioHealth Appoints Olivier Jarry, Former Head of Diabetes Care at Bayer and Executive at Novartis and Bristol-Myers-Squibb, as President and Chief Commercial Officer

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Olivier Jarry, a prominent global life sciences and consumer health executive, has joined the Company as President and Chief Commercial Officer. Mr. Jarry will be based in the U.S. and will lead DarioHealth's efforts relating to global revenue generation including B2B sales and data monetization.

View Analyst & Ambassador Comments
Go to original news
Sep 05,2018

Fit4D (now named Cecelia Health) Raises Additional $4 Million To Fuel Growth and Product Innovation

Fit4D (now named Cecelia Health), a leading diabetes management technology services company based in New York City, announced an expansion financing led by existing investor SJF Ventures with new investors C&B Capital, Esther Dyson and North Haven Capital. Existing investors Blue Cross and Blue Shield of Nebraska and StartUp Health also participated in the round.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 10,2018

Insulet Announces Shacey Petrovic, President and COO, Promoted to CEO, Effective January 1, 2019; Patrick Sullivan Will Retire as Chairman and CEO at the End of 2018

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that Shacey Petrovic, President and Chief Operating Officer, will succeed Patrick Sullivan as Insulet’s Chief Executive Officer, effective January 1, 2019. She will continue to serve as Insulet’s President.

View Analyst & Ambassador Comments
Go to original news
Sep 11,2018

Why Vida Might Just Be the Best Health App Ever

Vida Health offers personalized health coaching through an app. But can it help you reach your goals? Read this to learn the pros and cons of Vida.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES